A phase I study of DX 8951f (exatecan mesylate for injection) in patients with renal dysfunction

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.2069 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 2069-2069

Author(s):

C. J. Sweeney ◽

M. W. Saif ◽

P. M. Lorusso ◽

M. P. Ducharme ◽

R. Demnati ◽

...

Keyword(s):

Phase I ◽

Renal Dysfunction ◽

Phase I Study ◽

Exatecan Mesylate

Download Full-text

A phase I study of DX 8951f (exatecan mesylate for injection) in patients with renal dysfunction

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.2069 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 2069-2069 ◽

Author(s):

C. J. Sweeney ◽

M. W. Saif ◽

P. M. Lorusso ◽

M. P. Ducharme ◽

R. Demnati ◽

...

Keyword(s):

Phase I ◽

Renal Dysfunction ◽

Phase I Study ◽

Exatecan Mesylate

Download Full-text

Early phase I study of the PARP inhibitor veliparib (ABT-888) alone or in combination with carboplatin/paclitaxel (CP) in patients with varying degrees of hepatic or renal dysfunction: A study of the NCI-Organ Dysfunction Working Group (ODG).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.2572 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 2572-2572

Author(s):

Hussein Abdul-Hassan Tawbi ◽

Edward Chu ◽

Yan Lin ◽

David Michael Hyman ◽

Sanjay Goel ◽

...

Keyword(s):

Phase I ◽

Renal Dysfunction ◽

Organ Dysfunction ◽

Early Phase ◽

Working Group ◽

Phase I Study ◽

Download Full-text

Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70507-4 ◽

2007 ◽

Vol 2007 ◽

pp. 342-343

Author(s):

M.S. Gordon

Keyword(s):

Malignant Melanoma ◽

Phase I ◽

Phase I Study ◽

Advanced Malignant Melanoma

Download Full-text

Toxicity reduction of adenovirus mediated thymidine kinase gene therapy for ovarian cancer and subsequent combination with topoisomerase inhibitors: Design of a clinical phase I study

Journal of the Society for Gynecologic Investigation ◽

10.1016/s1071-5576(97)86111-4 ◽

1998 ◽

Vol 5 (1) ◽

pp. 47A-47A ◽

Author(s):

X TONG ◽

D ENGEHAUSEN ◽

D SHINE ◽

I AGOULNIK ◽

T KIM ◽

...

Keyword(s):

Ovarian Cancer ◽

Gene Therapy ◽

Phase I ◽

Thymidine Kinase ◽

Phase I Study ◽

Thymidine Kinase Gene ◽

Topoisomerase Inhibitors ◽

Kinase Gene ◽

Clinical Phase ◽

Toxicity Reduction

Download Full-text

Final results of the first phase I study of intraperitoneal administration of GL-ONC1, a marker gene modified vaccinia virus, in patients with peritoneal carcinomatosis

Zeitschrift für Gastroenterologie ◽

10.1055/s-0035-1559230 ◽

2015 ◽

Vol 53 (08) ◽

Author(s):

U Lauer ◽

M Zimmermann ◽

J Beil ◽

S Berchtold ◽

U Koppenhöfer ◽

...

Keyword(s):

Phase I ◽

Vaccinia Virus ◽

Peritoneal Carcinomatosis ◽

Phase I Study ◽

Marker Gene ◽

Intraperitoneal Administration

Download Full-text

Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma

10.1055/s-0040-1701850 ◽

2020 ◽

Author(s):

Y Koga ◽

M Sekimizu ◽

A Iguchi ◽

A Kada ◽

A Saito ◽

...

Keyword(s):

Phase I ◽

Anaplastic Large Cell Lymphoma ◽

Phase I Study ◽

Hodgkin’S Lymphoma ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

Hodgkin's Lymphoma ◽

Japanese Children ◽

Large Cell Lymphoma

Download Full-text

Sotagliflozin Multiple-dose Phase I Study in Healthy Chinese Subjects

Case Medical Research ◽

10.31525/ct1-nct03909451 ◽

2019 ◽

Author(s):

Keyword(s):

Phase I ◽

Phase I Study ◽

Multiple Dose ◽

Healthy Chinese ◽

Chinese Subjects

Download Full-text

Phase I Study MR-guided SBRT to PCa

Case Medical Research ◽

10.31525/ct1-nct03935308 ◽

2019 ◽

Author(s):

Keyword(s):

Phase I ◽

Download Full-text

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Younger Adults With Relapsed/Refractory B-cell ALL

Case Medical Research ◽

10.31525/ct1-nct03962465 ◽

2019 ◽

Author(s):

Keyword(s):

Phase I ◽

B Cell ◽

Phase I Study ◽

Download Full-text

A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

Case Medical Research ◽

10.31525/ct1-nct03971916 ◽

2019 ◽

Author(s):

Keyword(s):

Phase I ◽

Phase I Study ◽

Healthy Chinese

Download Full-text